Cargando…

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea

BACKGROUND: Topical α-adrenergic agonist therapy has been developed to treat the persistent erythema of rosacea patients. Brimonidine and oxymetazoline are both topical α-adrenergic agonists. OBJECTIVES: The objective of this in vitro safety pharmacology study was to compare the potential safety pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piwnica, David, Pathak, Atul, Schäfer, Gregor, Docherty, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833911/ https://www.ncbi.nlm.nih.gov/pubmed/29374829 http://dx.doi.org/10.1007/s40268-018-0227-y

Ejemplares similares

Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
por: Gil, Daniel
Publicado: (2018)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability
por: Anderson, Michael S, et al.
Publicado: (2017)

Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy
por: Docherty, James R., et al.
Publicado: (2016)

Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
por: Johnson, Andrew William, et al.
Publicado: (2015)

Altered pharmacological effects of adrenergic agonists during hypothermia
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2016)

The Efficacy and Safety of Dual-Frequency Ultrasound for Improving Skin Hydration and Erythema in Patients with Rosacea and Acne
por: Kim, Young Jae, et al.
Publicado: (2021)

Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society
por: Baldwin, Hilary E., et al.
Publicado: (2019)

Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey
por: Dirschka, Thomas, et al.
Publicado: (2015)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis
por: Bewley, Anthony, et al.
Publicado: (2016)

Suppression of the cough reflex by α(2)-adrenergic receptor agonists in the rabbit
por: Cinelli, Elenia, et al.
Publicado: (2013)

Structural basis of agonist specificity of α(1A)-adrenergic receptor
por: Su, Minfei, et al.
Publicado: (2023)

Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis
por: Bewley, Anthony, et al.
Publicado: (2016)

Evaluation of a simple image‐based tool to quantify facial erythema in rosacea during treatment
por: Logger, Jade G. M., et al.
Publicado: (2020)

Objectively quantifying facial erythema in rosacea aided by the ImageJ analysis of VISIA red images
por: Tao, Meng, et al.
Publicado: (2022)

Effect Of α2-Adrenergic Agonists And Antagonists On Cytokine Release From Human Lung Macrophages Cultured In Vitro
por: Piazza, O., et al.
Publicado: (2016)

Erythema Gyratum Repens Like Figurate Erythema Responding to Topical Steroid in an Healthy Individual
por: Naveen, Kikkeri Narayanasetty, et al.
Publicado: (2013)

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020)

Erythema Dyschromicum Perstans: Response to Topical Tacrolimus
por: Mahajan, Vikram K, et al.
Publicado: (2015)

Neuronal ensembles sufficient for recovery sleep and the sedative actions of α(2) adrenergic agonists
por: Zhang, Zhe, et al.
Publicado: (2015)

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016)

An α2-Adrenergic Agonist, Brimonidine, Beneficially Affects the TGF-β2-Treated Cellular Properties in an In Vitro Culture Model
por: Watanabe, Megumi, et al.
Publicado: (2022)

Altered Expression Profile of Renal α (1D)-Adrenergic Receptor in Diabetes and Its Modulation by PPAR Agonists
por: Zhao, Xueying, et al.
Publicado: (2014)

Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models
por: Thibaut de Ménonville, Séverine, et al.
Publicado: (2017)

Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
por: Steinhoff, Martin, et al.
Publicado: (2016)

Randomised controlled trial of topical kanuka honey for the treatment of rosacea
por: Braithwaite, Irene, et al.
Publicado: (2015)

Physiology and pharmacology of the cardiovascular adrenergic system
por: Lymperopoulos, Anastasios
Publicado: (2013)

Safety and efficacy of doxycycline in the treatment of rosacea
por: Valentín, Sheila, et al.
Publicado: (2009)

Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis—systematic review protocol
por: Torbahn, Gabriel, et al.
Publicado: (2016)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

Staying awake – a genetic region that hinders α(2) adrenergic receptor agonist-induced sleep
por: Gelegen, Cigdem, et al.
Publicado: (2014)

α-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study
por: Liu, Yan, et al.
Publicado: (2017)

Clonidine, an α2 adrenergic receptor agonist, disrupts reconsolidation of a cocaine-paired environmental memory
por: Denny, Rachel R., et al.
Publicado: (2019)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Retraction: Physiology and Pharmacology of the Cardiovascular Adrenergic System
Publicado: (2015)

The Clinical Pharmacology of Beta Adrenergic Blocking Drugs
por: McDevitt, D. G., et al.
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_5lopa89enltrotsj9ce1ke3d5d